N
FURX

Natixis’s FURIEX PHARMACEUTICALS INC COM STK (DE) FURX Stock Holding History

Natixis’s Portfolio FURX Stock Details FURX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-6,500
Closed -$690K – 521
2014
Q2 		$690K Buy
+6,500
New +$637K 0.01% 341

Natixis's FURX Position: Q3 2014 in Review

Natixis sold out of FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) in Q3 2014, closing a stake of 6,500 shares — an estimated $690K sold.

Natixis first reported a position in FURX in Q2 2014 and held it in 1 quarter. The position peaked at $690K in Q2 2014. 0 funds tracked by Wall St. Rank hold FURX as of Q3 2014.

  • Natixis reported no remaining FURIEX PHARMACEUTICALS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • Natixis sold 6,500 FURIEX PHARMACEUTICALS INC COM STK (DE) shares in Q3 2014, an estimated $690K.
  • Natixis first reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) in Q2 2014 and held it in 1 quarter.
  • Natixis's FURIEX PHARMACEUTICALS INC COM STK (DE) position peaked at $690K in Q2 2014.
  • 0 funds tracked by Wall St. Rank held FURIEX PHARMACEUTICALS INC COM STK (DE) as of Q3 2014.

Based on Natixis's 13F filing for Q3 2014, filed 14 Nov 2014.